Representing a pharmaceutical company following Health Canada’s rejection of a new drug submission

Fasken Martineau was retained by a US manufacturer of medical devices in the context of a dispute following the rejection by Health Canada of a medical device submission. Fasken Martineau successfully reversed Health Canada’s decision by determining that Health Canada had incorrectly classified the product as a “drug” when it was instead a “medical device”.